scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0092-8674(04)00132-1 |
P8608 | Fatcat ID | release_7pe5gwoadbhctljvc2x7rqjvxe |
P698 | PubMed publication ID | 14980221 |
P50 | author | Luca Proietti De Santis | Q73188989 |
Nicolas Le May | Q64403649 | ||
P2093 | author name string | Jean-Marc Egly | |
Agnès Billecocq | |||
Michèle Bouloy | |||
Sandy Dubaele | |||
P2860 | cites work | Isolation and characterization of two human transcription factor IIH (TFIIH)-related complexes: ERCC2/CAK and TFIIH | Q24309302 |
Human cyclin-dependent kinase-activating kinase exists in three distinct complexes | Q24309353 | ||
p44 and p34 subunits of the BTF2/TFIIH transcription factor have homologies with SSL1, a yeast protein involved in DNA repair | Q24315493 | ||
Substrate specificity of the cdk-activating kinase (CAK) is altered upon association with TFIIH | Q24532143 | ||
Differential viral induction of distinct interferon-alpha genes by positive feedback through interferon regulatory factor-7 | Q24533409 | ||
RNA synthesis in poliovirus-infected cells | Q76414286 | ||
TFIIH plays an essential role in RNA polymerase I transcription | Q27934158 | ||
The xeroderma pigmentosum group D (XPD) gene: one gene, two functions, three diseases | Q28142591 | ||
Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH | Q28285305 | ||
Reconstitution of the transcription factor TFIIH: assignment of functions for the three enzymatic subunits, XPB, XPD, and cdk7 | Q28646653 | ||
Transcription factor IIH: a key player in the cellular response to DNA damage | Q33601019 | ||
Cytopathogenesis and inhibition of host gene expression by RNA viruses | Q34010277 | ||
Vector competence of Egyptian mosquitoes for Rift Valley fever virus. | Q34377721 | ||
Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis | Q34625091 | ||
Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. | Q35000433 | ||
Genomic sequence analysis of the mouse Naip gene array | Q35028777 | ||
The transcriptional complexity of the TFIIH complex | Q35556199 | ||
Inhibition of basal transcription by poliovirus: a virus- encoded protease (3Cpro) inhibits formation of TBP-TATA box complex in vitro | Q35860088 | ||
Core filaments of the nuclear matrix | Q36222649 | ||
The effect of Mengovirus infection on the activity of the DNA-dependent RNA polymerase of L-cells | Q36395940 | ||
Different dynamics in nuclear entry of subunits of the repair/transcription factor TFIIH | Q38678701 | ||
Epidemic Rift Valley fever in Egypt: observations of the spectrum of human illness | Q39162251 | ||
The S segment of rift valley fever phlebovirus (Bunyaviridae) carries determinants for attenuation and virulence in mice | Q39588385 | ||
Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs | Q39601913 | ||
Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya | Q40635980 | ||
Characterization of clone 13, a naturally attenuated avirulent isolate of Rift Valley fever virus, which is altered in the small segment. | Q40679919 | ||
Sequences and coding strategies of the S RNAs of Toscana and Rift Valley fever viruses compared to those of Punta Toro, Sicilian sandfly fever, and Uukuniemi viruses | Q40752380 | ||
Demonstration of Nuclear Immunofluorescence in Rift Valley Fever Infected Cells | Q40766157 | ||
Identification of a major non-structural protein in the nuclei of Rift Valley fever virus-infected cells | Q40844168 | ||
Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID. | Q42464743 | ||
The MO15 cell cycle kinase is associated with the TFIIH transcription-DNA repair factor | Q42494377 | ||
XPD mutations prevent TFIIH-dependent transactivation by nuclear receptors and phosphorylation of RARalpha | Q43960571 | ||
Inhibition of transcription factor activity by poliovirus | Q44671921 | ||
Human general transcription factor IIH phosphorylates the C-terminal domain of RNA polymerase II | Q59098636 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Rift Valley fever phlebovirus | Q24809101 |
P1104 | number of pages | 10 | |
P304 | page(s) | 541-550 | |
P577 | publication date | 2004-02-01 | |
P1433 | published in | Cell | Q655814 |
P1476 | title | TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus | |
P478 | volume | 116 |
Q33316823 | A SAP30 complex inhibits IFN-beta expression in Rift Valley fever virus infected cells. |
Q26748369 | A Tale of Two RNAs during Viral Infection: How Viruses Antagonize mRNAs and Small Non-Coding RNAs in The Host Cell |
Q36747779 | A five-amino-acid deletion of the eastern equine encephalitis virus capsid protein attenuates replication in mammalian systems but not in mosquito cells |
Q40186455 | A glycoprotein subunit vaccine elicits a strong Rift Valley fever virus neutralizing antibody response in sheep. |
Q92129404 | A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape |
Q39640664 | A silencing suppressor protein (NSs) of a tospovirus enhances baculovirus replication in permissive and semipermissive insect cell lines. |
Q59335452 | A single-cycle replicable Rift Valley fever phlebovirus vaccine carrying a mutated NSs confers full protection from lethal challenge in mice |
Q35616459 | A ΩXaV motif in the Rift Valley fever virus NSs protein is essential for degrading p62, forming nuclear filaments and virulence |
Q35077969 | Advances in Rift Valley fever research: insights for disease prevention |
Q33927167 | Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection |
Q34031858 | Anti-nucleocapsid protein immune responses counteract pathogenic effects of Rift Valley fever virus infection in mice |
Q54217244 | Attenuation and efficacy of live-attenuated Rift Valley fever virus vaccine candidates in non-human primates. |
Q37509225 | Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKR. |
Q39248221 | Bunyaviridae RdRps: structure, motifs, and RNA synthesis machinery |
Q56537260 | Bunyavirus: Hemorrhagic Fevers |
Q38613824 | Bunyaviruses and the type I interferon system |
Q59351865 | CD4 T cells, CD8 T cells, and monocytes coordinate to prevent Rift Valley fever virus encephalitis |
Q27478382 | Capsid Protein of Eastern Equine Encephalitis Virus Inhibits Host Cell Gene Expression |
Q28486276 | Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virus |
Q40448667 | Characterization of Rift Valley fever virus transcriptional terminations. |
Q40199478 | Comparative efficacy of two next-generation Rift Valley fever vaccines |
Q27478367 | Complete Genome Analysis of 33 Ecologically and Biologically Diverse Rift Valley Fever Virus Strains Reveals Widespread Virus Movement and Low Genetic Diversity due to Recent Common Ancestry |
Q27330115 | Correlative Gene Expression to Protective Seroconversion in Rift Valley Fever Vaccinates |
Q33705717 | Countermeasure development for Rift Valley fever: deletion, modification or targeting of major virulence factor NSs |
Q34281104 | Culex pipiens, an experimental efficient vector of West Nile and Rift Valley fever viruses in the Maghreb region. |
Q34785767 | Cullin E3 ligases and their rewiring by viral factors |
Q36286082 | Curcumin inhibits Rift Valley fever virus replication in human cells. |
Q41929716 | Current Status of Rift Valley Fever Vaccine Development |
Q35097798 | Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes |
Q42172999 | Demonstration of helicase activity in the nonstructural protein, NSs, of the negative-sense RNA virus, groundnut bud necrosis virus |
Q36559849 | Dicer-2- and Piwi-mediated RNA interference in Rift Valley fever virus-infected mosquito cells |
Q33443358 | Differential Antagonism of Human Innate Immune Responses by Tick-Borne Phlebovirus Nonstructural Proteins |
Q40101969 | Discovery and characterisation of a new insect-specific bunyavirus from Culex mosquitoes captured in northern Australia |
Q37336396 | Discovery of a unique novel clade of mosquito-associated bunyaviruses |
Q42425012 | Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses |
Q35107614 | Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. |
Q33911860 | Efficient cDNA-based rescue of La Crosse bunyaviruses expressing or lacking the nonstructural protein NSs. |
Q39893246 | Efficient production of Rift Valley fever virus-like particles: The antiviral protein MxA can inhibit primary transcription of bunyaviruses |
Q36874347 | Epidemiology, molecular virology and diagnostics of Schmallenberg virus, an emerging orthobunyavirus in Europe |
Q33781530 | Expression profiling of human hepatoma cells reveals global repression of genes involved in cell proliferation, growth, and apoptosis upon infection with parvovirus H-1 |
Q34429914 | Functional analysis of Rift Valley fever virus NSs encoding a partial truncation |
Q44170263 | Genetic stability of Rift Valley fever virus MP-12 vaccine during serial passages in culture cells |
Q36414512 | Genetic subpopulations of Rift Valley fever virus strains ZH548 and MP-12 and recombinant MP-12 strains |
Q40141993 | Hepatitis C Virus NS5A Targets Nucleosome Assembly Protein NAP1L1 To Control the Innate Cellular Response |
Q24324685 | Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses |
Q33918307 | Host alternation is necessary to maintain the genome stability of rift valley fever virus |
Q35185886 | Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3 |
Q100385804 | Identification of a herpes simplex virus 1 gene encoding neurovirulence factor by chemical proteomics |
Q35801885 | Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication |
Q34260234 | Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection |
Q33781480 | Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. |
Q40554311 | Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist |
Q24670740 | Interaction of Bunyamwera Orthobunyavirus NSs protein with mediator protein MED8: a mechanism for inhibiting the interferon response |
Q37332576 | Interferon and cytokine responses to Crimean Congo hemorrhagic fever virus; an emerging and neglected viral zonoosis |
Q34536954 | Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. |
Q34660504 | Interferon, Mx, and viral countermeasures |
Q52563024 | Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20. |
Q27480353 | La Crosse Bunyavirus Nonstructural Protein NSs Serves To Suppress the Type I Interferon System of Mammalian Hosts |
Q40277454 | Large-scale chromatin immunoprecipitation with promoter sequence microarray analysis of the interaction of the NSs protein of Rift Valley fever virus with regulatory DNA regions of the host genome |
Q27469610 | Loss of interferon regulatory factor 3 in cells infected with classical swine fever virus involves the N-terminal protease, Npro |
Q35792819 | MP-12 virus containing the clone 13 deletion in the NSs gene prevents lethal disease when administered after Rift Valley fever virus infection in hamsters |
Q28554535 | Mechanistic Insight into the Host Transcription Inhibition Function of Rift Valley Fever Virus NSs and Its Importance in Virulence |
Q36650409 | Minigenomes, transcription and replication competent virus-like particles and beyond: reverse genetics systems for filoviruses and other negative stranded hemorrhagic fever viruses |
Q57017486 | Molecular Biology of Rift Valley Fever Virus~!2009-11-04~!2009-11-25~!2010-04-22~! |
Q36652695 | Molecular biology and genetic diversity of Rift Valley fever virus |
Q33886954 | Molecular biology of rift valley Fever virus |
Q40048134 | Multiple virus lineages sharing recent common ancestry were associated with a Large Rift Valley fever outbreak among livestock in Kenya during 2006-2007. |
Q54257544 | Mutation of adjacent cysteine residues in the NSs protein of Rift Valley fever virus results in loss of virulence in mice. |
Q37049951 | Mutational Analysis of the Rift Valley Fever Virus Glycoprotein Precursor Proteins for Gn Protein Expression. |
Q36315241 | NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis |
Q59352330 | NSs Protein of Sandfly Fever Sicilian Phlebovirus Counteracts Interferon (IFN) Induction by Masking the DNA-Binding Domain of IFN Regulatory Factor 3 |
Q38774860 | NSs Virulence Factor of Rift Valley Fever Virus Engages the F-Box Proteins FBXW11 and β-TRCP1 To Degrade the Antiviral Protein Kinase PKR |
Q39960501 | NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription |
Q39195523 | NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase |
Q39547955 | NSs protein of rift valley fever virus promotes posttranslational downregulation of the TFIIH subunit p62. |
Q38150190 | Non-structural proteins of arthropod-borne bunyaviruses: roles and functions |
Q39778891 | Nonstructural NSs protein of rift valley fever virus interacts with pericentromeric DNA sequences of the host cell, inducing chromosome cohesion and segregation defects. |
Q37252699 | Nuclear relocalization of polyadenylate binding protein during rift valley fever virus infection involves expression of the NSs gene |
Q26747457 | Phleboviruses and the Type I Interferon Response |
Q48097495 | Phosphoproteomic analysis reveals Smad protein family activation following Rift Valley fever virus infection |
Q36879979 | Post-exposure vaccination with MP-12 lacking NSs protects mice against lethal Rift Valley fever virus challenge |
Q36568775 | Presence of Viral RNA and Proteins in Exosomes from Cellular Clones Resistant to Rift Valley Fever Virus Infection |
Q27485881 | Processing of Genome 5′ Termini as a Strategy of Negative-Strand RNA Viruses to Avoid RIG-I-Dependent Interferon Induction |
Q40365121 | Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by different DNA vaccination regimens. |
Q37439419 | Punta Toro virus (Bunyaviridae, Phlebovirus) infection in mice: strain differences in pathogenesis and host interferon response |
Q39586531 | Quantitative analysis of particles, genomes and infectious particles in supernatants of haemorrhagic fever virus cell cultures |
Q38217394 | RIG-I-like receptors and negative-strand RNA viruses: RLRly bird catches some worms |
Q33883819 | RING-H2 protein WSSV249 from white spot syndrome virus sequesters a shrimp ubiquitin-conjugating enzyme, PvUbc, for viral pathogenesis |
Q36759999 | RNA helicase signaling is critical for type i interferon production and protection against Rift Valley fever virus during mucosal challenge |
Q27491320 | Rapid Accumulation of Virulent Rift Valley Fever Virus in Mice from an Attenuated Virus Carrying a Single Nucleotide Substitution in the M RNA |
Q40311587 | Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene |
Q38614407 | Restriction of rift valley Fever virus virulence in mosquito cells |
Q36276510 | Reverse genetics recovery of Lujo virus and role of virus RNA secondary structures in efficient virus growth |
Q33570326 | Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines |
Q33745109 | Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift valley fever virus in human small airway epithelial cells |
Q34475358 | Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments. |
Q40038707 | Rift Valley fever phlebovirus NSs protein core domain structure suggests molecular basis for nuclear filaments |
Q37006803 | Rift Valley fever virus MP-12 vaccine encoding Toscana virus NSs retains neuroinvasiveness in mice |
Q40137585 | Rift Valley fever virus NSS gene expression correlates with a defect in nuclear mRNA export |
Q36501737 | Rift Valley fever virus NSs inhibits host transcription independently of the degradation of dsRNA-dependent protein kinase PKR. |
Q40499504 | Rift Valley fever virus NSs mRNA is transcribed from an incoming anti-viral-sense S RNA segment |
Q26745530 | Rift Valley fever virus NSs protein functions and the similarity to other bunyavirus NSs proteins |
Q33406230 | Rift Valley fever virus NSs protein promotes post-transcriptional downregulation of protein kinase PKR and inhibits eIF2alpha phosphorylation |
Q36827204 | Rift Valley fever virus clearance and protection from neurologic disease are dependent on CD4+ T cell and virus-specific antibody responses |
Q37634027 | Rift Valley fever virus infection induces activation of the NLRP3 inflammasome |
Q40308414 | Rift Valley fever virus inhibits a pro-inflammatory response in experimentally infected human monocyte derived macrophages and a pro-inflammatory cytokine response may be associated with patient survival during natural infection. |
Q40237478 | Rift Valley fever virus structural and nonstructural proteins: recombinant protein expression and immunoreactivity against antisera from sheep. |
Q34221766 | Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep |
Q33960690 | Rift Valley fever virus(Bunyaviridae: Phlebovirus): an update on pathogenesis, molecular epidemiology, vectors, diagnostics and prevention |
Q28539632 | Rift valley Fever virus encephalitis is associated with an ineffective systemic immune response and activated T cell infiltration into the CNS in an immunocompetent mouse model |
Q55332018 | Rift valley fever viral load correlates with the human inflammatory response and coagulation pathway abnormalities in humans with hemorrhagic manifestations. |
Q36484009 | Rift valley fever virus lacking the NSs and NSm genes is highly attenuated, confers protective immunity from virulent virus challenge, and allows for differential identification of infected and vaccinated animals |
Q33755025 | Rift valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system |
Q34174444 | Rift valley fever: recent insights into pathogenesis and prevention |
Q54247042 | SFTS phlebovirus promotes LC3-II accumulation and nonstructural protein of SFTS phlebovirus co-localizes with autophagy proteins. |
Q34233569 | Searching for cellular partners of hantaviral nonstructural protein NSs: Y2H screening of mouse cDNA library and analysis of cellular interactome |
Q35036515 | Severe acute respiratory syndrome coronavirus nsp1 protein suppresses host gene expression by promoting host mRNA degradation |
Q40008303 | Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells |
Q37433779 | Short Interfering RNA Inhibits Rift Valley Fever Virus Replication and Degradation of Protein Kinase R in Human Cells |
Q36326847 | Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates |
Q35868079 | Single-dose immunization with virus replicon particles confers rapid robust protection against Rift Valley fever virus challenge |
Q38152910 | Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit. |
Q27682730 | Structural insights into RNA encapsidation and helical assembly of the Toscana virus nucleoprotein |
Q33401401 | Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus |
Q35059373 | TFIIH subunit alterations causing xeroderma pigmentosum and trichothiodystrophy specifically disturb several steps during transcription |
Q38008913 | TFIIH: when transcription met DNA repair. |
Q33486526 | TLR2-dependent inhibition of macrophage responses to IFN-gamma is mediated by distinct, gene-specific mechanisms |
Q35679057 | Targeting TFIIH to inhibit host cell transcription by Rift Valley Fever Virus |
Q26796199 | Temperature-sensitive mutations for live-attenuated Rift Valley fever vaccines: implications from other RNA viruses |
Q39430510 | The Andes hantavirus NSs protein is expressed from the viral small mRNA by a leaky scanning mechanism |
Q37099848 | The C proteins of human parainfluenza virus type 1 (HPIV1) control the transcription of a broad array of cellular genes that would otherwise respond to HPIV1 infection |
Q36694012 | The L, M, and S Segments of Rift Valley Fever Virus MP-12 Vaccine Independently Contribute to a Temperature-Sensitive Phenotype |
Q27485926 | The NSm proteins of Rift Valley fever virus are dispensable for maturation, replication and infection |
Q33602836 | The NSs protein of tomato spotted wilt virus is required for persistent infection and transmission by Frankliniella occidentalis |
Q40208169 | The Old World and New World alphaviruses use different virus-specific proteins for induction of transcriptional shutoff |
Q34354086 | The Rift Valley Fever virus protein NSm and putative cellular protein interactions |
Q35097103 | The consequences of reconfiguring the ambisense S genome segment of Rift Valley fever virus on viral replication in mammalian and mosquito cells and for genome packaging |
Q36155392 | The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccine |
Q52319133 | The essential and multi-functional TFIIH complex. |
Q39943779 | The interferon antagonist ML protein of thogoto virus targets general transcription factor IIB. |
Q36346824 | The interferon response circuit: induction and suppression by pathogenic viruses |
Q40049455 | The matrix protein of vesicular stomatitis virus inhibits host-directed transcription of target genes via interaction with the TFIIH subunit p8. |
Q40306367 | The nonstructural protein NSs induces a variable antibody response in domestic ruminants naturally infected with Rift Valley fever virus |
Q34191969 | The pathogenesis of Rift Valley fever |
Q31034150 | The role of interferon antagonist, non-structural proteins in the pathogenesis and emergence of arboviruses |
Q39672712 | The role of signal transducer and activator of transcription 3 in Rift Valley fever virus infection |
Q37509231 | The two faces of Rift Valley fever virus virulence factor NSs: The development of a vaccine and the elucidation of pathogenesis |
Q24337813 | Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I |
Q36759758 | Toscana virus NSs protein promotes degradation of double-stranded RNA-dependent protein kinase |
Q36096753 | Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses |
Q64938159 | Transcriptome profiling in Rift Valley fever virus infected cells reveals modified transcriptional and alternative splicing programs. |
Q40134923 | Truncation of the C-terminal region of Toscana Virus NSs protein is critical for interferon-β antagonism and protein stability |
Q40026123 | Tula hantavirus isolate with the full-length ORF for nonstructural protein NSs survives for more consequent passages in interferon-competent cells than the isolate having truncated NSs ORF |
Q36701186 | Unique SARS-CoV protein nsp1: bioinformatics, biochemistry and potential effects on virulence |
Q40237435 | Using click chemistry to measure the effect of viral infection on host-cell RNA synthesis |
Q35841573 | Using reverse genetics to manipulate the NSs gene of the Rift Valley fever virus MP-12 strain to improve vaccine safety and efficacy |
Q40399200 | Vaccination with virus-like particles protects mice from lethal infection of Rift Valley Fever Virus |
Q36750723 | Viral suppression of the interferon system |
Q55097752 | Viral targeting of TFIIB impairs de novo polymerase II recruitment and affects antiviral immunity. |
Q38326807 | Virulence factor NSs of rift valley fever virus recruits the F-box protein FBXO3 to degrade subunit p62 of general transcription factor TFIIH |
Q24319790 | p53 Activation following Rift Valley fever virus infection contributes to cell death and viral production |
Q36434009 | β-Catenin Upregulates the Constitutive and Virus-Induced Transcriptional Capacity of the Interferon Beta Promoter through T-Cell Factor Binding Sites |
Search more.